Evidence map›Paper›PMID 39962186›Full record

ArticleScientific reports2025

A recursive embedding and clustering technique for unraveling asymptomatic kidney disease using laboratory data and machine learning.

Eman Alqaissi, Abdulmohsen Algarni, Mohammed Alshehri, Husain Alkhaldy, Afnan Alshehri

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eman AlqaissiCentral Labs, King Khalid University, P.O. Box 960, AlQura'a, Abha, Saudi Arabia. ealqasy@kku.edu.sa.
Abdulmohsen AlgarniCentral Labs, King Khalid University, P.O. Box 960, AlQura'a, Abha, Saudi Arabia.
Mohammed AlshehriNephrology Section, Internal Medicine Department, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.
Husain AlkhaldyHematology Section, Internal Medicine Department, College of Medicine, King Khalid University, Abha, 61421, Saudi Arabia.
Afnan AlshehriInformatics and Computer Systems, King Khalid University, Abha, Saudi Arabia.

Funding

The University Higher Education funds this research work under the Research Support Program for Central Labs at King Khalid University CL/CO/C/6'
6 · The paper itself

Abstract

Traditional methods for diagnosing chronic kidney disease (CKD) via laboratory data may not be capable of identifying early kidney disease. Kidney biopsy is unsuitable for regular screening, and imaging tests are costly and time-consuming. Several studies have implemented artificial intelligence (AI) to detect CKD. However, these studies used small datasets, had overfitting problems, lacked generalizability, or used complex algorithms that may require additional computational resources. In this study, we collected and analyzed center-based data and used a recursive embedding and clustering technique to reduce their dimensionality. We identified three clusters from 1600 records. We focused on the second cluster, as most of the characteristics had values in the normal ranges. Normal range values for most indicators generally represent stable kidney function with minor signs of strain, which often remain asymptomatic. Creatinine and eGFR levels within the threshold ranges indicate early kidney stress without filtration issues, which require close monitoring. The gradient-boosting algorithm showed superior performance among all algorithms in detecting these clusters. We evaluated an additional 400 unlabeled records to validate our method. This research can help clinicians automatically detect initial signs in numerous patients via routine tests to prevent the consequences of late-stage CKD detection.

Indexed as

Machine LearningRenal Insufficiency, ChronicAdultAgedAlgorithmsAsymptomatic DiseasesCluster AnalysisCreatinineFemaleGlomerular Filtration RateHumansMaleMiddle AgedCreatinineChronic kidney diseaseClusteringEmbeddingGradient boostingIdentification at earlier stagesLaboratory data

Identifiers

PMID39962186
PMCPMC11832896

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.